Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
Study Identifier:
TRIUMPH
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete
Study Details
Medical Condition
- Unmapped
Study Drug
- Drug: eculizumab
Date
Oct 2004 - N/A
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18+ years
Requirements Information
Sex
Female & Male
Age
18+ years
Study Details
Medical Condition
- Unmapped
Study Drug
- Drug: eculizumab
Date
Oct 2004 - N/A
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18+ years years
Requirements Information
Protocol Summary
The primary objective is to evaluate the safety and efficacy of eculizumab in transfusion dependent patients with hemolytic PNH.
Trial Locations
Location
Status
Location
City of Hope National Medical Center, Div. of Hematology & Bone Marrow Transplant
Duarte, California, United States, 91010-3000
Status
N/A
Location
University of California at Los Angeles
Los Angeles, California, United States, 90024
Status
N/A
Location
Scripps Cancer Center
San Diego, California, United States, 92121
Status
N/A
Location
Stanford University Medical Center, Division of Hematology
Stanford, California, United States, 94305-5821
Status
N/A
Location
Hartford Hospital, Cancer Clinical Research Office
Hartford, Connecticut, United States, 06102
Status
N/A
Location
Cleveland Clinic, Dept. of Clinical Research
Weston, Florida, United States, 33331
Status
N/A